Innate Pharma Market Cap

Innate Pharma has a market cap or net worth of €110.53 million as of April 28, 2026. Its market cap has decreased by -24.90% in one year.

Market Cap

110.53M

Enterprise Value

98.79M

Revenue

9.01M

Ranking

n/a

PE Ratio

n/a

Stock Price

€1.18

Market Cap Chart

Since November 1, 2006, Innate Pharma's market cap has increased from 792.12K to 110.53M, an increase of 13,853.79%. That is a compound annual growth rate of 28.82%.

Market Cap History

Date	Market Cap	% Change
Apr 28, 2026	110.53M	-25.15%
Dec 31, 2025	147.67M	-7.67%
Dec 31, 2024	159.94M	-24.29%
Dec 29, 2023	211.24M	-19.93%
Dec 30, 2022	263.84M	-24.98%
Dec 31, 2021	351.67M	28.64%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
MaaT Pharma	102.89M
Adocia	90.87M
ABIONYX Pharma	127.00M
Valerio Therapeutics Société anonyme	76.26M
OSE Immunotherapeutics	67.80M
Sensorion	194.82M
Transgene	207.33M
Fermentalg	51.49M

Market Cap Rankings